Ignite Creation Date:
2024-05-06 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 12:51 PM
Study NCT ID:
NCT03631615
Status:
UNKNOWN
Last Update Posted:
2020-08-26
First Post:
2018-08-13
Brief Title:
Neoadjuvant Chemoradiation Plus PD-1 AntibodySHR-1210 in Locally Advanced Proximal Stomach Adenocarcinoma
Sponsor:
Shanghai Zhongshan Hospital
Organization:
Shanghai Zhongshan Hospital
Organization Data
Organization:
Shanghai Zhongshan Hospital
Class:
OTHER
Study ID:
SHR-1210-CRT-GC-IIT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai Zhongshan Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Tianshu Liu
Responsible Party Title:
Director of Oncology Department
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Shanghai Zhongshan Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Jiangsu HengRui Medicine Co Ltd | INDUSTRY |